| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | CA2702754A1 Process for making glucocorticoid receptor ligands |
| 04/30/2009 | CA2702269A1 Fungicidal compounds, processes for their preparation and their use for controlling harmful fungi, and compositions comprising them |
| 04/29/2009 | EP2051985A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof |
| 04/29/2009 | EP2051966A2 Heterocycles useful as inhibitors of carbonic anhydrase |
| 04/29/2009 | EP2051707A2 Inhibitors of plasma kallikrein |
| 04/29/2009 | EP1551403B1 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421218A Cycloalkyl-phenylsubstituierte cyclische ketoenole |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/29/2009 | CN100482647C Pyrazole derivatives useful as COX-I inhibitors |
| 04/28/2009 | US7524964 Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524871 Thrombin inhibitors |
| 04/28/2009 | US7524868 Cannabinoid 1 receptor antagonists, high binding affinity; N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H -pyrazole-3-carboxamide; bulimia, obesity, non-insulin-dependent diabetes |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | US7524838 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/23/2009 | WO2009052231A1 Crystalline chemotherapeutic |
| 04/23/2009 | WO2009052230A1 Crystalline chemotherapeutic |
| 04/23/2009 | WO2009052229A1 Crystalline chemotherapeutic |
| 04/23/2009 | WO2009052226A1 Crystalline indazole-derived chemotherepeutic |
| 04/23/2009 | WO2009052225A1 Crystalline chemotherapeutic |
| 04/23/2009 | WO2009051910A1 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009051245A1 3-alkoxy-1-phenylpyrazole derivative and pest control agent |
| 04/23/2009 | WO2009050394A2 Use of cyclovinyl phosphine/copper complexes as arylation catalysts |
| 04/23/2009 | WO2009050354A1 Isopropanol solvate of rimonabant, preparation method thereof and pharmaceutical compositions containing same |
| 04/23/2009 | WO2009050353A1 3-methylbutan-1-ol solvate of rimonabant, preparation method thereof and pharmaceutical compositions containing same |
| 04/23/2009 | WO2009050318A1 Pyrazole derivatives of fatty acid amides as ppar-alpha receptor specific activators, preparation method thereof and use of same |
| 04/23/2009 | WO2009050244A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050243A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050221A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050220A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050218A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009024342A3 Novel microbiocides |
| 04/23/2009 | WO2009013211A3 New pyrazol derivatives |
| 04/23/2009 | WO2009006061A3 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | WO2006138453A3 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base |
| 04/23/2009 | US20090105486 Crystalline Chemotherapeutic |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105326 Crystalline Chemotherapeutic |
| 04/23/2009 | US20090105325 Substituted Pyrazolecarboxylic Acid Anilide Derivative or Salt Thereof, Intermediate Thereof, Agent for Agricultural and Horticultural Use, and Use Thereof |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/23/2009 | CA2699356A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699354A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699353A1 Crystalline chemotherapeutic |
| 04/23/2009 | CA2699352A1 Crystalline indazole-derived chemotherepeutic |
| 04/23/2009 | CA2699302A1 Crystalline chemotherapeutic |
| 04/22/2009 | EP2050467A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 04/22/2009 | EP2049496A2 3-difluoromethylpyrazolylcarboxanilides |
| 04/22/2009 | EP2049495A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/22/2009 | EP2049482A1 Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415686A Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 04/22/2009 | CN101415685A Kinase inhibitors and methods of use thereof |
| 04/22/2009 | CN101412696A 4,5-diaryl pyrazole-3-amido derivative, and preparation and use thereof |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521397 1-Methyl-3-di- or trifluoromethyl-4-pyrazolyl-o-fluorophenylfluorocarboxanilides: N-(3',4'-difluoro-3-fluoro-1,1'-biphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide; plant fungicides |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009046802A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
| 04/16/2009 | WO2009006267A3 N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
| 04/16/2009 | WO2008130630A4 Polymorphic form of rimonabant hydrochloride and processes for preparation thereof |
| 04/16/2009 | WO2008035356A3 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099236 treatment of depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; methyl-[3-(3-methyl-1H-indazol-5-yl)-3-phenyl- propyl]-amine |
| 04/16/2009 | US20090099209 Compounds Useful in Therapy |
| 04/16/2009 | US20090099189 CRTH2 Receptor Ligands For Medicinal Uses |
| 04/16/2009 | US20090099143 Tetrahydro-indazole cannabinoid modulators |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | CA2701839A1 N- (pyrazole-3-yl) -benzamide derivatives as glucokinase activators |
| 04/15/2009 | EP2048137A1 Benzamide derivatives and their use as glucokinase activating agents. |
| 04/15/2009 | EP2046754A2 Method for producing alkylanilides from halobenzene derivatives |
| 04/15/2009 | EP1689720B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 04/15/2009 | CN101410379A Process for preparing retinoid compounds |
| 04/15/2009 | CN101410375A Method for producing aromatic compound |
| 04/15/2009 | CN101407496A Method for synthesizing 3,5-disubstituted pyrazole |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/14/2009 | US7518000 For therapy of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK); 2-(1H-thieno[3,2-c]pyrazol-3-yl)-1H-benzimidazole |
| 04/14/2009 | US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |
| 04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517983 Hydrazines and derivatives production process from hydrazines and dicarboxylic acid |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517902 1-[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl-phenyl)urea; protein kinases (Vascular Endothelial Growth Factor Receptor 2 and Tie-2), inhibitor; anticarcinogenic, antiinflammatory agent; neovascularization, lung and breast cancer, rheumatoid arthritis |